Clinical trial
Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75
NCT00416208 is registered in ClinicalTrials.gov with Janssen-Cilag G.m.b.H as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75
- Lead sponsor
- Janssen-Cilag G.m.b.H
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- May 31, 2013
- Enrollment
- 154 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.